Showing results (211-220 of 672) with videos related to
Sort By:
Pageof 68
Biochimica Et Biophysica Acta|April 13, 2007
Safety issues and prospects for future generations of PPAR modulatorsAnne Rubenstrunk, Rémy Hanf, Dean W Hum, et al.Chemmedchem|February 7, 2009
Characterization of new PPARgamma agonists: analysis of telmisartan's structural componentsMatthias Goebel, Markus Clemenz, Bart Staels, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|March 5, 2003
Rupture of the atherosclerotic plaque: does a good animal model exist?Paul Cullen, Roberta Baetta, Stefano Bellosta, et al.Molecular Metabolism|September 23, 2016
Demonstration of a day-night rhythm in human skeletal muscle oxidative capacityDirk van Moorsel, Jan Hansen, Bas Havekes, et al.Obesity Surgery|December 18, 2016
Fasting Circulating Glicentin Increases After Bariatric SurgeryJuliette Raffort, Patricia Panaïa-Ferrari, Fabien Lareyre, et al.The Journal of Clinical Endocrinology and Metabolism|September 23, 2017
Bile Acid Alterations Are Associated With Insulin Resistance, but Not With NASH, in Obese SubjectsVanessa Legry, Sven Francque, Joel T Haas, et al.Biochemical and Biophysical Research Communications|February 6, 2007
PPARdelta, but not PPARalpha, activates PGC-1alpha gene transcription in muscleElayne Hondares, Inés Pineda-Torra, Roser Iglesias, et al.Molecular Endocrinology (Baltimore, Md.)|May 8, 2004
The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alphaChristophe Blanquart, Roxane Mansouri, Réjane Paumelle, et al.Journal of Cardiovascular Pharmacology|April 13, 2004
Fenofibrate increases homocystinemia through a PPARalpha-mediated mechanismGérald Luc, Nelly Jacob, Muriel Bouly, et al.Nature|March 6, 2009
Type II fatty acid synthesis is not a suitable antibiotic target for Gram-positive pathogensSophie Brinster, Gilles Lamberet, Bart Staels, et al.Pageof 68